| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2001 | WO2001013953A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 03/01/2001 | WO2001013950A1 Percutaneous absorption agents |
| 03/01/2001 | WO2001013938A1 Medicinal composition for percutaneous/permucosal absorption |
| 03/01/2001 | WO2001013932A2 Stimulation of sperm function |
| 03/01/2001 | WO2001013927A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 03/01/2001 | WO2001013924A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | WO2001013920A1 Carnitine analogues as topical, microbicidal spermicides |
| 03/01/2001 | WO2001013918A1 Treatment of urinary incontinence |
| 03/01/2001 | WO2001013915A1 Cataplasms containing vitamin c or its derivative |
| 03/01/2001 | WO2001013913A1 Compositions containing esters for treating parasitic infestations of organisms |
| 03/01/2001 | WO2001013906A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | WO2001013903A2 Treatment of restless leg syndrome with a combination of clonidine and opioid |
| 03/01/2001 | WO2001013902A2 Combination of active agents, said combination containing clonidine and pramipexol |
| 03/01/2001 | WO2001013901A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 03/01/2001 | WO2001013899A2 Therapeutic system containing an active substance and comprising at least two polymerous layers |
| 03/01/2001 | WO2001013898A2 Pharmaceutical formulations with different release times |
| 03/01/2001 | WO2001013897A1 Oral liquid compositions |
| 03/01/2001 | WO2001013896A1 A vaccine composition and method of using the same |
| 03/01/2001 | WO2001013895A2 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 03/01/2001 | WO2001013894A1 Gabapentin tablet and method of making with improved physical and chemical characteristics |
| 03/01/2001 | WO2001013893A2 Use of simple amino acids to form porous particles |
| 03/01/2001 | WO2001013892A2 Large porous particles by spray-drying |
| 03/01/2001 | WO2001013891A2 Modulation of release from dry powder formulations |
| 03/01/2001 | WO2001013890A1 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants |
| 03/01/2001 | WO2001013889A1 Pharmaceutical composition comprising nabumetone |
| 03/01/2001 | WO2001013888A1 Liposome preparations for external use |
| 03/01/2001 | WO2001013887A2 Phospholipin gel |
| 03/01/2001 | WO2001013886A1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 03/01/2001 | WO2001013885A1 Method to produce powders for pulmonary or nasal administration |
| 03/01/2001 | WO2001013884A2 Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 03/01/2001 | WO2001013883A1 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 03/01/2001 | WO2001013865A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 03/01/2001 | WO2001013864A1 Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
| 03/01/2001 | WO2001013780A2 Apparatus and method for anesthetizing the cervical region of a female |
| 03/01/2001 | WO2001003670A9 Method for controlled production of ultrafine microparticles and nanoparticles |
| 03/01/2001 | WO2001000181A3 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 03/01/2001 | WO2000078297A3 Stable xylometazoline and oxymetazoline solution |
| 03/01/2001 | WO2000072953A3 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products |
| 03/01/2001 | WO2000071146A3 Glutathione reductase for therapy and prophylaxis of aids |
| 03/01/2001 | WO2000061190A3 Treatment of intracellular infection |
| 03/01/2001 | WO2000061141A3 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| 03/01/2001 | WO2000061115A3 Pharmaceutical formulation comprising amoxycillin |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000030660A3 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 03/01/2001 | WO2000023037A8 Two chamber cartridge for atomizers |
| 03/01/2001 | WO1998042379A3 Chemically and thermally stable norastemizole formulations |
| 03/01/2001 | DE19941024A1 Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung Drug product for veterinary application and process for its production |
| 03/01/2001 | DE19940795A1 Schnellzerfallende Pellets auf der Basis von Chitosan Rapidly disintegrating pellets based on chitosan |
| 03/01/2001 | DE19940794A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | DE19940242A1 Applying a preparation in liquid phase containing active substances to a substrate constituting an adhesive therapeutic system involves use of a free jet similarly to bubble jet printing |
| 03/01/2001 | DE19940241A1 Method for applying at least one active substance to a thin substrate forming a carrier layer involves use of liquid active substances which are applicable by bubble jet printing techniques |
| 03/01/2001 | DE19940239A1 Cosmetic or medicinal dressing, especially useful for treating chronic skin disorders, comprises a reusable textile backing and a disposable insert coated or impregnated with cosmetic or medicinal agents |
| 03/01/2001 | DE19940238A1 Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten Active substance-containing therapeutic system for application to the skin comprising at least two polymer-containing layers |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | CA2715683A1 Synergistic combination |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383491A1 Large porous particles by spray-drying |
| 03/01/2001 | CA2383019A1 Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof |
| 03/01/2001 | CA2382867A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | CA2382821A1 Modulation of release from dry powder formulations |
| 03/01/2001 | CA2382670A1 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | CA2382652A1 A vaccine composition and method of using the same |
| 03/01/2001 | CA2382648A1 Drug treatment for restless leg syndrome |
| 03/01/2001 | CA2382220A1 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | CA2382218A1 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants |
| 03/01/2001 | CA2382217A1 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
| 03/01/2001 | CA2382216A1 Method to produce powders for pulmonary or nasal administration |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2381571A1 Phospholipid gel |
| 03/01/2001 | CA2381468A1 Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 03/01/2001 | CA2380730A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | CA2380333A1 Pharmaceutical formulations |
| 03/01/2001 | CA2379982A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376606A1 Active substance combination with clonidine |
| 03/01/2001 | CA2376269A1 Process for producing fine medicinal substances |
| 03/01/2001 | CA2376180A1 Oral liquid compositions |
| 02/28/2001 | EP1078638A1 Additive for improving the water resistance of cosmetic or dermatological formulations |
| 02/28/2001 | EP1078636A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/28/2001 | EP1078628A2 Multiple unit tableted dosage form |
| 02/28/2001 | EP1078627A1 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/28/2001 | EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 02/28/2001 | EP1077988A1 Crystal form 0 of clarithromycin |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077760A1 Methods and apparatus for particle formation |
| 02/28/2001 | EP1077727A1 Adhesive microsphere drug delivery composition |
| 02/28/2001 | EP1077726A2 Inhibiting undesirable taste in oral compositions |
| 02/28/2001 | EP1077722A2 Methods and products for inducing mucosal immunity |
| 02/28/2001 | EP1077717A2 Use of lipopeptides or lipoproteins for wound treatment |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077711A2 Treatment of papilloma virus infection using a mycobacterium |
| 02/28/2001 | EP1077709A1 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/28/2001 | EP1077708A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 02/28/2001 | EP1077707A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 02/28/2001 | EP1077703A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 02/28/2001 | EP1077692A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 02/28/2001 | EP1077691A1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |